Endexx Corp
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0427
- Today's High:
- $0.0508
- Open Price:
- $0.0508
- 52W Low:
- $0.006
- 52W High:
- $0.1
- Prev. Close:
- $0.0475
- Volume:
- 102951
Company Statistics
- Market Cap.:
- $21.12 million
- Book Value:
- -0.027
- Revenue TTM:
- $3.70 million
- Operating Margin TTM:
- -72.85%
- Gross Profit TTM:
- $503009
- Profit Margin:
- -40.91%
- Return on Assets TTM:
- -22.98%
- Return on Equity TTM:
- -1208.83%
Company Profile
Endexx Corp had its IPO on under the ticker symbol EDXC.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Endexx Corp has a staff strength of 0 employees.
Stock update
Shares of Endexx Corp opened at $0.05 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.04 - $0.05, and closed at $0.05.
This is a +2.11% increase from the previous day's closing price.
A total volume of 102,951 shares were traded at the close of the day’s session.
In the last one week, shares of Endexx Corp have increased by +5.66%.
Endexx Corp's Key Ratios
Endexx Corp has a market cap of $21.12 million, indicating a price to book ratio of 0 and a price to sales ratio of 19.8139.
In the last 12-months Endexx Corp’s revenue was $3.70 million with a gross profit of $503009 and an EBITDA of $-2678098. The EBITDA ratio measures Endexx Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Endexx Corp’s operating margin was -72.85% while its return on assets stood at -22.98% with a return of equity of -1208.83%.
In Q1, Endexx Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 864.9%.
Endexx Corp’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Endexx Corp’s profitability.
Endexx Corp stock is trading at a EV to sales ratio of 27.9819 and a EV to EBITDA ratio of -2.0219. Its price to sales ratio in the trailing 12-months stood at 19.8139.
Endexx Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $12.88 million
- Total Liabilities
- $20.37 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Endexx Corp ended 2025 with $12.88 million in total assets and $0 in total liabilities. Its intangible assets were valued at $12.88 million while shareholder equity stood at $-13056326.00.
Endexx Corp ended 2025 with $0 in deferred long-term liabilities, $20.37 million in other current liabilities, 50410.00 in common stock, $-46208070.00 in retained earnings and $9.81 million in goodwill. Its cash balance stood at $154812.00 and cash and short-term investments were $154812.00. The company’s total short-term debt was $7,383,378 while long-term debt stood at $4.35 million.
Endexx Corp’s total current assets stands at $2.99 million while long-term investments were $420.00 and short-term investments were $0. Its net receivables were $425345.00 compared to accounts payable of $3.05 million and inventory worth $644971.00.
In 2025, Endexx Corp's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Endexx Corp paid $0 in dividends in 2025.
Other key metrics
- Current Trading Price
- $0.05
- 52-Week High
- $0.1
- 52-Week Low
- $0.006
- Analyst Target Price
- $
Endexx Corp stock is currently trading at $0.05 per share. It touched a 52-week high of $0.1 and a 52-week low of $0.1. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.04 and 200-day moving average was $0.04 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 558% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Endexx Corp
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Endexx Corporation engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market. It provides CBD creams, oils, capsules, extracts, topicals, drinks, chocolates, and pet products, as well as hemp-derived health and beauty care products for supporting the relief of pain and inflammation for humans and pets through its e-commerce site cbdunlimited.com, as well as other online and in-store retailers. The company was formerly known as CBD Unlimited, Inc. and changed its name to Endexx Corporation in May 2020. Endexx Corporation is headquartered in Cave Creek, Arizona.